Ginkgo Bioworks Holdings: TD Cowen Lowers Price Target to $12.00, Maintains Buy Rating

TD Cowen lowers Ginkgo Bioworks Holdings' (DNA) price target from $14.00 to $12.00, but maintains a 'Buy' rating. Analyst Brendan Smith's adjustment reflects confidence in the company's long-term prospects, despite adjusted valuations. The average target price is $10.00, with a high estimate of $12.00 and a low estimate of $9.00. The average brokerage recommendation is 4.0, indicating "Underperform" status. The estimated GF Value for Ginkgo Bioworks Holdings in one year is $15.12, suggesting a 62.41% upside from the current price.